OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical Effectiveness of Regdanvimab Treatment for Mild-to-Moderate COVID-19: A Retrospective Cohort Study
Young Rock Jang, Yoon Ju Oh, Jin Yong Kim
Current Therapeutic Research (2022) Vol. 96, pp. 100675-100675
Open Access | Times Cited: 5
Young Rock Jang, Yoon Ju Oh, Jin Yong Kim
Current Therapeutic Research (2022) Vol. 96, pp. 100675-100675
Open Access | Times Cited: 5
Showing 5 citing articles:
Effectiveness of regdanvimab on mortality in COVID-19 infected patients on hemodialysis
Youn Kyung Kee, Hayne Cho Park, Su Jin Yoon, et al.
Kidney Research and Clinical Practice (2024) Vol. 43, Iss. 1, pp. 111-121
Open Access
Youn Kyung Kee, Hayne Cho Park, Su Jin Yoon, et al.
Kidney Research and Clinical Practice (2024) Vol. 43, Iss. 1, pp. 111-121
Open Access
CLINICAL EFFECTIVENESS OF REGDANVIMAB IN THE TREATMENT OF PATIENTS WITH COVID-19: A SYSTEMATIC REVIEW AND META-ANALYSIS
Morteza Zaboli Mahdiabadi, Zahra Abbasi Dolatabadi, Fatemeh Nemati Dopolani, et al.
Studies in Medical Sciences (2023) Vol. 33, Iss. 11, pp. 786-795
Open Access | Times Cited: 1
Morteza Zaboli Mahdiabadi, Zahra Abbasi Dolatabadi, Fatemeh Nemati Dopolani, et al.
Studies in Medical Sciences (2023) Vol. 33, Iss. 11, pp. 786-795
Open Access | Times Cited: 1
Efficacy and safety of regdanvimab in patients with mild to moderate COVID‐19: A rapid review and meta‐analysis
Behnam Amani, Bahman Amani
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 4, pp. 1282-1290
Open Access
Behnam Amani, Bahman Amani
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 4, pp. 1282-1290
Open Access
Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea
Ji Yeon Lee, Seon Hee Bu, Eun-Hyang Song, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 10, pp. 2417-2435
Open Access
Ji Yeon Lee, Seon Hee Bu, Eun-Hyang Song, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 10, pp. 2417-2435
Open Access
Effectiveness of Regdanvimab and Remdesivir in Patients with COVID-19 at a Single Hospital
Sunmo Kim, Hwee-Soo Jeong, Jisun Lim, et al.
Korean Journal of Family Practice (2022) Vol. 12, Iss. 5, pp. 340-345
Open Access
Sunmo Kim, Hwee-Soo Jeong, Jisun Lim, et al.
Korean Journal of Family Practice (2022) Vol. 12, Iss. 5, pp. 340-345
Open Access
